Yoko Iwase
Niigata University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yoko Iwase.
PLOS ONE | 2016
Issei Saitoh; Masahiro Sato; Miki Soda; Emi Inada; Yoko Iwase; Tomoya Murakami; Hayato Ohshima; Haruaki Hayasaki; Hirofumi Noguchi
Type 1 diabetes occurs due to the autoimmune destruction of pancreatic β-cells in islets. Transplantation of islets is a promising option for the treatment of patients with type 1 diabetes that experience hypoglycemic unawareness despite maximal care, but the present shortage of donor islets hampers such transplantation. Transplantation of insulin-producing cells derived from the patients themselves would be one of the most promising approaches to cure type 1 diabetes. Previously, we demonstrated that insulin-producing cells could be produced by transfecting murine pancreatic cells with Yamanaka’s reprogramming factors. Non-obese diabetic (NOD) mice are naturally occurring mutant mice defective in insulin production due to autoimmune ablation of pancreatic β-cells. In this study, we showed that glucose-sensitive insulin-producing cells are successfully generated by transfecting primary pancreatic cells from NOD mice (aged 6 months old) with a plasmid harboring the cDNAs for Oct-3/4, Sox2, Klf4, and c-Myc. Transfection was repeated 4 times in a 2 day-interval. Sixty-five days after final transfection, cobblestone-like colonies appeared. They proliferated in vitro and expressed pluripotency-related genes as well as Pdx1, a transcription factor specific to tissue-specific stem cells for the β-cell lineage. Transplantation of these cells into nude mice failed to produce teratoma unlike induced pluripotent stem cells (iPSCs). Induction of these cells to the pancreatic β-cell lineage demonstrated their capability to produce insulin in response to glucose. These findings suggest that functional pancreatic β-cells can be produced from patients with type 1 diabetes. We call these resultant cells as “induced tissue-specific stem cells from the pancreas” (iTS-P) that could be valuable sources of safe and effective materials for cell-based therapy in type 1 diabetes.
Clinical Oral Investigations | 2014
Yuki Tosaka; Kuniko Nakakura-Ohshima; Nozomi Murakami; Rikako Ishii; Issei Saitoh; Yoko Iwase; Akihiro Yoshihara; Akitsugu Ohuchi; Haruaki Hayasaki
ObjectiveThe aim of this study was to demonstrate the effectiveness of an analysis of tooth brushing cycles using a system that measures tooth brushing motion and brushing force with an accelerometer and strain tension gage attached to a toothbrush.BackgroundMechanical plaque removal with a manual toothbrush remains the primary method of maintaining good oral hygiene for the majority of the population. Because toothbrush motion has not been fully understood, it should be clarified by analysis of tooth brushing cycles.MethodsTwenty healthy female dental hygienists participated in this study. Their tooth brushing motions were measured and analyzed using an American Dental Association-approved manual toothbrush to which a three-dimensional (3-D) accelerometer and strain tension gage were attached. 3-D motion and brushing force on the labial surface of the mandibular right central incisor and the lingual surface of the mandibular left first molar were measured, analyzed, and compared. Multilevel linear model analysis was applied to estimate variables and compare motion and forces related to the two tooth surfaces.ResultsThe analysis of tooth brushing cycles was feasible, and significant differences were detected for durations and 3-D ranges of toothbrush motion as well as brushing force between the two tooth surfaces.ConclusionThe analysis used in this study demonstrated an ability to detect characteristics of tooth brushing motion, showing tooth brushing motion to change depending on the brushed location. These results also suggest that more detailed instructions might be required according to patient’s oral condition.
Archives of Oral Biology | 2017
Tomoya Murakami; Issei Saitoh; Masahiro Sato; Emi Inada; Miki Soda; Masataka Oda; Hisanori Domon; Yoko Iwase; Tadashi Sawami; Kazunari Matsueda; Yutaka Terao; Hayato Ohshima; Hirofumi Noguchi; Haruaki Hayasaki
OBJECTIVE Lymphoid enhancer-binding factor-1 (LEF1) is a 48-kD nuclear protein that is expressed in pre-B and T cells. LEF1 is also an important member of the Wnt/β-catenin signaling pathway that plays important roles in the self-renewal and differentiation of embryonic stem cells. We speculated that LEF1 might function in the stem cells from human exfoliated deciduous teeth (SHED). In this study, we attempted to isolate such LEF1-positive cells from human deciduous dental pulp cells (HDDPCs) by genetic engineering technology, using the human LEF1 promoter. DESIGN A piggyBac transposon plasmid (pTA-LEN) was introduced into HDDPCs, using the Neon® transfection system. After G418 selection, the emerging colonies were assessed for EGFP-derived fluorescence by fluorescence microscopy. Reverse transcription polymerase chain reaction (RT-PCR) analysis was performed using RNA isolated from these colonies to examine stem cell-specific transcript expression. Osteoblastic or neuronal differentiation was induced by cultivating the LEF1-positive cells with differentiation-inducing medium. RESULTS RT-PCR analysis confirmed the expression of several stem cell markers, including OCT3/4, SOX2, REX1, and NANOG, in LEF1-positive HDDPCs, which could be differentiated into osteoblasts and neuronal cells. CONCLUSIONS The isolated LEF1-positive HDDPCs exhibited the properties of stem cells, suggesting that LEF1 might serve as a marker for SHED.
Japanese Dental Science Review | 2014
Haruaki Hayasaki; Issei Saitoh; Kuniko Nakakura-Ohshima; Mika Hanasaki; Yukiko Nogami; Tsutomu Nakajima; Emi Inada; Tomonori Iwasaki; Yoko Iwase; Tadashi Sawami; Katsushige Kawasaki; Nozomi Murakami; Tomoya Murakami; Mie Kurosawa; Masami Kimi; Akiko Kagoshima; Miki Soda; Youich Yamasaki
Journal of Atherosclerosis and Thrombosis | 2014
Atsushi Kohjitani; Masaaki Miyata; Yoko Iwase; Sachi Ohno; Akina Tohya; Yozo Manabe; Teruto Hashiguchi; Kazuna Sugiyama
Clinical Oral Investigations | 2015
Emi Inada; Issei Saitoh; Yong Yu; Daisuke Tomiyama; Daisuke Murakami; Yoshihiko Takemoto; Ken Morizono; Tomonori Iwasaki; Yoko Iwase; Youichi Yamasaki
Clinical advances in periodontics | 2018
Issei Saitoh; Mie Kurosawa; Haruka Nagai; Toru Fujii; You Aoyagi; Kuniko Nakakura-Ohshima; Yoko Iwase; Haruaki Hayasaki; Tetsuo Shirakawa
Pediatric Dental Journal | 2017
Issei Saitoh; Emi Inada; Yasutaka Kaihara; Yukiko Nogami; Daisuke Murakami; Norihito Ishitani; Tadashi Sawami; Yoko Iwase; Tsutomu Nakajima; Naoko Kubota; Kaoru Sakurai; Toshiya Tsujii; Yoshito Shirazawa; Mika Hanasaki; Mie Kurosawa; Miyuki Goto; Maki Nosou; Katsuyuki Kozai; Youichi Yamasaki; Haruaki Hayasaki
Pediatric Dental Journal | 2017
Tsutomu Nakajima; Yoko Iwase; Issei Saitoh; Yukiko Nogami; Kazunari Matsueda; Haruaki Hayasaki
Pediatric Dental Journal | 2017
Issei Saitoh; Satoshi Fukumoto; Yoko Iwase; Haruaki Hayasaki; Youichi Yamasaki